Feasibility project for a clinical study in Israel - Swedish SME’s & Israeli hospital
| Reference number | |
| Coordinator | IAROCA AB |
| Funding from Vinnova | SEK 100 000 |
| Project duration | January 2025 - May 2025 |
| Status | Completed |
| Venture | Cooperation between Sweden och Israel |
| Call | Planning grants for collaborations with small, smart countries; Singapore or Israel |
Important results from the project
The project is conducting a feasibility study between Acorai AB, Key2Compliance AB and Clalit North/Meir Medical in Israel, with the aim of determining the feasibility and defining a project plan for a potential clinical trial in Israel. The project is important for increasing the collection of data in different populations, which will improve the machine learning algorithms of Acorai´s solution, ensure compliance with regulatory standards, and lead to knowledge exchange between the countries.
Expected long term effects
The feasibility study has focused on building a long-term partnership between Acorai, Key2Compliance and Clalit North/Meir Medical, leading to knowledge exchange and potential for long-term collaborations. The project has focused on defining the feasibility and – if possible – a project plan for a clinical study in Israel. The project supports the development of sustainable precision health in an international context while integrating climate and equality into the this & future collaborations.
Approach and implementation
The project is a collaboration between all three project parties and is divided into five activities: 1) Start of the project & preparations - Online meetings & discussions, reporting & project agreement 2) Personal meeting in Israel (Filip Peters and Uri Goren) - Travel expected in April 2025 3) Follow-up meetings, start of project plan - Discussions about future collaborations 4) Creation of project plan - If possible, a structured plan for next steps 5) End of project & final project plan